BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Portfolio holdings
AUM
$924M
This Quarter Return
-8.24%
1 Year Return
+18.54%
3 Year Return
+67.81%
5 Year Return
+208.44%
10 Year Return
+508.52%
AUM
$1.77B
AUM Growth
+$1.77B
(+11%)
Cap. Flow
+$355M
Cap. Flow
% of AUM
20.08%
Top 10 Holdings %
Top 10 Hldgs %
97.54%
Holding
48
New
6
Increased
3
Reduced
2
Closed
8
Top Buys
| 1 |
iShares MSCI EAFE ETF
EFA
|
$258M |
| 2 |
Microsoft
MSFT
|
$205M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$117M |
| 4 |
Light & Wonder
LNW
|
$25.9M |
| 5 |
GRNA
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
|
$16.4M |
Top Sells
| 1 |
EQT Corp
EQT
|
$154M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$110M |
| 3 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$3.36M |
| 4 |
Nautilus Biotechnolgy
NAUT
|
$1.6M |
| 5 |
Douglas Emmett
DEI
|
$1.22M |
Sector Composition
| 1 | Communication Services | 12.01% |
| 2 | Technology | 11.8% |
| 3 | Consumer Discretionary | 7.42% |
| 4 | Healthcare | 3.7% |
| 5 | Consumer Staples | 1.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares MSCI EAFE ETF
EFA
$66B
| $416M | 23.52% |
5,653,424
+3,505,000
| +163% | +$258M |
|
2
iShares MSCI Emerging Markets ETF
EEM
$19B
| $375M | 21.21% |
8,313,046
| – | – |
|
3
iShares Core MSCI Emerging Markets ETF
IEMG
$102B
| $320M | 18.06% |
5,752,009
| – | – |
|
|
4
Alphabet (Google) Class A
GOOGL
$2.57T
| $212M | 12% |
76,331
+42,081
| +123% | +$117M |
|
|
5
Microsoft
MSFT
$3.77T
| $205M | 11.6% |
+665,738
| New | +$205M |
|
|
6
Light & Wonder
LNW
$7.76B
| $73.6M | 4.16% |
1,253,039
+440,147
| +54% | +$25.9M |
|
7
QuantumScape
QS
$4.49B
| $57.5M | 3.25% |
2,874,742
| – | – |
|
8
Krispy Kreme
DNUT
$608M
| $32.5M | 1.84% |
2,187,760
| – | – |
|
|
AKYA
9
DELISTED
Akoya BioSciences
AKYA
| $17.3M | 0.98% |
1,572,863
-52,695
| -3% | -$579K |
|
|
GRNA
10
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
| $16.4M | 0.93% |
+1,706,078
| New | +$16.4M |
|
11
Lyell Immunopharma
LYEL
$213M
| $8.32M | 0.47% |
1,647,882
| – | – |
|
12
Kodiak Sciences
KOD
$478M
| $5.34M | 0.3% |
691,767
| – | – |
|
|
LENZ
13
LENZ Therapeutics
LENZ
$1.1B
| $3.59M | 0.2% |
703,071
| – | – |
|
14
BridgeBio Pharma
BBIO
$9.89B
| $3.36M | 0.19% |
331,283
| – | – |
|
15
Surrozen
SRZN
$104M
| $2.43M | 0.14% |
806,374
| – | – |
|
16
Doximity
DOCS
$12.7B
| $2.16M | 0.12% |
41,484
| – | – |
|
17
Confluent
CFLT
$6.85B
| $2.13M | 0.12% |
+51,876
| New | +$2.13M |
|
18
Black Stone Minerals
BSM
$2.58B
| $1.99M | 0.11% |
147,852
| – | – |
|
19
Bolt Biotherapeutics
BOLT
$9.85M
| $1.97M | 0.11% |
719,546
| – | – |
|
20
Kimbell Royalty Partners
KRP
$1.3B
| $1.82M | 0.1% |
111,638
| – | – |
|
21
Annexon
ANNX
$226M
| $1.32M | 0.07% |
482,550
| – | – |
|
22
Planet Labs
PL
$2.15B
| $1.3M | 0.07% |
256,445
| – | – |
|
|
DICE
23
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $1.12M | 0.06% |
58,492
-175,422
| -75% | -$3.36M |
|
24
DigitalOcean
DOCN
$2.97B
| $1.05M | 0.06% |
18,147
| – | – |
|
25
KALA BIO
KALA
$78.8M
| $950K | 0.05% |
+688,701
| New | +$950K |
|